Filing Details

Accession Number:
0001179110-20-007739
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-23 20:38:15
Reporting Period:
2020-06-21
Accepted Time:
2020-06-23 20:38:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1697362 Burkes Michael Brophy C/O Natera, Inc., 201 Industrial Road
Suite 410
San Carlos CA 94070
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-21 1,117 $0.00 42,139 No 4 M Direct
Common Stock Acquisiton 2020-06-22 1,077 $0.00 43,216 No 4 M Direct
Common Stock Disposition 2020-06-22 448 $46.47 42,768 No 4 S Direct
Common Stock Disposition 2020-06-23 1,626 $10.41 44,394 No 4 M Direct
Common Stock Disposition 2020-06-23 2,295 $45.51 42,099 No 4 S Direct
Common Stock Disposition 2020-06-23 433 $45.51 41,666 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2020-06-21 1,117 $0.00 1,117 $0.00
Common Stock Restricted Stock Unit Disposition 2020-06-22 1,077 $0.00 1,077 $0.00
Common Stock Stock Option (right to buy) Disposition 2020-06-23 1,626 $0.00 1,626 $10.41
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,352 No 4 M Direct
11,850 No 4 M Direct
23,761 2027-06-08 No 4 M Direct
Footnotes
  1. Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting March 21, 2018.
  2. Each RSU represents a contingent right to receive one share of the common stock of the issuer.
  3. Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting March 22, 2020.
  4. The sale of shares was effected in order to satisfy tax liabilities due at the time of vesting.
  5. The sales reported in this Form 4 effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2019.
  6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.51 to $45.5275 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. The RSUs vest over four years. 25% of the RSUs vest on March 21, 2018 and the remaining shares vest in 12 equal quarterly installments thereafter.
  8. The RSUs vest over four years. 25% of the RSUs vest on March 22, 2020 and the remaining shares vest in 12 equal quarterly installments thereafter.
  9. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.